Magenta Therapeutics, Inc.
MGTA
NASDAQ
Headlines
9/5/2023
-
Ticker Report
8/14/2023
-
Bizjournals.com - Health Care News
8/8/2023
-
PR Newswire
8/7/2023
-
Business Wire
7/31/2023
-
SeekingAlpha
7/28/2023
-
SeekingAlpha
5/20/2023
-
Ticker Report
5/18/2023
-
PR Newswire
5/17/2023
-
Globe Newswire
5/14/2023
-
Globe Newswire
5/10/2023
-
Globe Newswire
5/10/2023
-
Globe Newswire
5/10/2023
-
Ticker Report
5/9/2023
-
Zolmax
5/4/2023
-
PR Newswire
5/4/2023
-
PR Newswire
5/4/2023
-
PR Newswire
5/4/2023
-
Business Wire
5/3/2023
-
Benzinga
5/3/2023
-
Bizjournals.com - Health Care News
5/3/2023
-
Business Wire
5/3/2023
-
Seeking Alpha - Healthcare
5/3/2023
-
Globe Newswire
Filings
Thursday, August 3, 2023
Friday, June 30, 2023
Beginning of November (est)
Corporate Info
857 242 0170
100 Technology Square
Cambridge, MA 02139
Cambridge, MA 02139
Business Description
As of September 11, 2023, Magenta Therapeutics, Inc. was acquired by Dianthus Therapeutics, Inc., in a reverse merger transaction. Magenta Therapeutics, Inc., a biotechnology company focus on...
more